Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Biological Chemistry|June 14, 2011
Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidaseAlexia Eliades, Nikolaos Papadantonakis, Ajoy Bhupatiraju, et al.Scientific Reports|April 7, 2022
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarkerDeepti Reddi, Brandon W Seaton, David Woolston, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activityYuou Wang, Anish Sen-Majumdar, Jian-Ming Li, et al.Leukemia & Lymphoma|July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete responseCaner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.Haematologica|October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemiaKeith W Pratz, Jason Kaplan, Moshe Levy, et al.The Journal of Biological Chemistry|January 1, 2026
Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activityYuou Wang, Anish Sen-Majumdar, Jian-Ming Li, et al.The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJason Gotlib, Aaron T Gerds, Prithviraj Bose, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019Patrick A Brown, Matthew Wieduwilt, Aaron Logan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.Pageof 3